Search PubMed⌕ Search

Biomedical subjects

C Cordova

Publications and source records attributed to C Cordova.

At least 91 records · Page 5Linked to original sources
PubMed1982

Amplitude and spectral quantification of the effects of morphine on the cortical EEG of the rat.

The effect of systemically administered morphine sulfate on the cortical EEG of the rat was studied using direct visual scoring procedures and spectral and amplitude distribution analysis techniques. The EEG effect was found to be dose-dependent, i.e., as higher doses of morphine were administered morphine-induced spindles or spike-like activity progressively increased and were eventually replaced by a highly synchronized EEG. In quantifying these EEG patterns, using spectral analysis, distinct frequency spectra were found for morphine-induced spindles and epochs of high voltage low frequency (HVLF) activity. The power in the 5-7 Hz frequency band was found to be a good indicator of the duration of the morphine effect since the value of this index was elevated during the time course of the drug effect. In addition, amplitude distribution methods revealed the sensitivity of two specific measures to the EEG changes induced by morphine. Values of standard amplitude followed closely the degree of EEG synchronization while kurtosis proved sensitive enough to follow the effect of specific doses of morphine sulfate.

Animals↗
PubMed1982

Influence of ascorbic acid on platelet aggregation in vitro and in vivo.

With the objective of investigating more thoroughly the relationship between ascorbic acid and platelet aggregation (PA) in particular, in vitro and in vivo studies were made whether interferences exist, Scaling amounts of ascorbic acid were added to platelet-rich plasma (PRP) samples to determine the level at which the inhibition of the PA was induce by ADP and arachidonic acid (AA), and endoplatelet malondialdehyde (MDA) concentrations decreased. Changes in PA and MDA were not observed in the PRP control samples Also, in 10 healthy volunteers, an i.v. infusion of ascorbic acid (2 g) produced PA inhibition and a reduction of MDA concentrations.

Ascorbic Acid↗
PubMed1982

Improvement of some blood coagulation factors in cirrhotic patients treated with low doses of heparin.

Effects of subcutaneous calcium-heparin and vitamin K administration were studied in 30 cirrhotic patients showing low values of prothrombin time, antithrombin III, fibrinogen, platelet count, plasminogen, alpha 2-antiplasmin, raised levels of fibrin(ogen) degradation products and prolonged activated partial thromboplastin time. A group of 10 patients was first treated with K vitamin for 15 d; after vitamin K therapy interruption, a treatment with 5000 IU (8000 IU in 1 patient) every 12 h of subcutaneous calcium-heparin was started. In another group of 20 patients a treatment with 5000 IU (8000 IU in 2 patients) every 12 h of subcutaneous calcium-heparin was started immediately. The heparin administration in both groups had been performed for at least 2 weeks. No significant changes of blood coagulation picture were observed after vitamin K administration, while calcium-heparin treatment showed an increase in prothrombin time, fibrinogen, platelet count, plasminogen, alpha 2-antiplasmin, a decrease in fibrin(ogen) degradation products and a shortened activated partial thromboplastin time. There was no significant change in antithrombin III values.

Blood Coagulation Factors↗